UPTD
Hello Traders
The price action declined further today . What is your opinion ?
Have a look my analysis and don’t forget to comment and like .
Thanks .
−996.10 KUSD
9.35 M
About Estrella Immunopharma, Inc.
Estrella Immunopharma, Inc. operates as a pre-clinical stage biopharmaceutical company, which engages in the development of T-cell therapies with the capacity to address treatment and safety challenges for patients with blood cancers and solid tumors. The company is headquartered in Emeryville, CA.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of ESLA is 1.02 USD — it has decreased by 1.92% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Estrella Immunopharma, Inc. stocks are traded under the ticker ESLA.
ESLA stock is 4.90% volatile and has beta coefficient of 2.27. Check out the list of the most volatile stocks — is Estrella Immunopharma, Inc. there?
Yes, you can track Estrella Immunopharma, Inc. financials in yearly and quarterly reports right on TradingView.
ESLA stock has risen by 3.03% compared to the previous week, the month change is a 5.56% fall, over the last year Estrella Immunopharma, Inc. has showed a 90.47% decrease.
ESLA net income for the last quarter is −1.02 M USD, while the quarter before that showed −1.87 M USD of net income which accounts for 45.44% change. Track more Estrella Immunopharma, Inc. financial stats to get the full picture.
Today Estrella Immunopharma, Inc. has the market capitalization of 37.34 M, it has decreased by 1.84% over the last week.
No, ESLA doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, ESLA shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Estrella Immunopharma, Inc. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Estrella Immunopharma, Inc. technincal analysis shows the strong sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Estrella Immunopharma, Inc. stock shows the sell signal. See more of Estrella Immunopharma, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.